ABSTRACT
Objective To explore the effect of hyperbaric oxygen combined with progressively controlled decompression on the prognosis of patients with emergency craniocerebral trauma.Methods Ninety-six patients with emergency craniocerebral trauma were selected as study subjects,and they were divided into observation group (n =50) and control group(n =46) according to the random number table.The observation group was treated by progressively controlled decompression combined with hyperbaric oxygen,while the control group was treated by standard large trauma craniotomy combined with hyperbaric oxygen.The incidence of perioperative complications,prognosis (evaluated by GOS) and activities of daily living(evaluated by ADL) were compared between the two groups.Results In the observation group,the incidence rates of perioperative acute encephalocele,delayed hematoma and postoperative cerebral infarction were 6.0％,10.0％,6.0％,respectively,which were lower than 19.6％,26.1％,21.7％ of the control group(x2 =4.031,4.255,5.069,all P ＜ 0.05).The good prognosis rate in the observation group was 62.0％,which was significantly higher than 39.1％ in the control group (x2 =5.014,P ＜ 0.05).There was no significant difference in ADL score between the two groups before treatment (t =0.347,P ＞ 0.05).After treatment,the ADL scores of the two groups were increased (t =5.673,8.223,all P ＜ 0.05).Meanwhile,the ADL score of the observation group was higher than that of the control group (t =2.920,P ＜ 0.05).Conclusion The application of progressively controlled decompression combined with hyperbaric oxygen in patients with emergency craniocerebral trauma is conductive to reduce acute encephalocele,bone window brain tissue incarceration,delayed hematoma,postoperative cerebral infarction and other complications.Besides,it can repair the damaged nerve cells,and eventually improve activities of daily living of patients and reduce morbidity and mortality,and the prognosis is better.
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the change of T lymphocyte subsets, interleukin (IL)-2 and tumor necrosis factor (TNF)-alpha in the tumor- bearing mice and patients with oral cancer receiving thermo-chemotherapy, and investigate the correlation among them.</p><p><b>METHODS</b>After treatments, the expression of lymphocyte transformation index (LTI), IL-2 and TNF-alpha in the tumor-bearing mice were detected with methyl thiazolyl tetrazolium (MTT), the expression of IL-2 and TNF-alpha in the patients with oral cancer were detected with MTT, the expression of LTI, CD4+ and CD8+ were detected with 3H-TdR incorporation.</p><p><b>RESULTS</b>LTI, IL-2 and TNF-alpha of thermo-chemotherapy group (HP group) had no significant difference comparing with those of normal mice group (N group) (P>0.05), but which were significantly higher than those of chemotherapy group (P group) and no treatment group (NT group) (P<0.01). In clinical trials, the expression of LTI, CD4+, CD4+/CD8+, IL-2 and TNF-alpha on oral cancer patients after thermo-chemotherapy were significantly higher than those before thermo-chemotherapy (P<0.01).</p><p><b>CONCLUSION</b>After thermo-chemotherapy, the expression of LTI, IL-2 and TNF-alpha of tumor-bearing hosts are significantly improved, there is a significant correlation between IL-2 and T cell.</p>
Subject(s)
Animals , Humans , Mice , Interleukin-2 , Mouth Neoplasms , Neoplasms , T-Lymphocyte Subsets , Tumor Necrosis Factor-alphaABSTRACT
To prepare recombinant fox growth hormone (fGH), we amplified its cDNA from silver fox pituitary tissue by RT-PCR and cloned into yeast shuttle vector pPIC9K down stream of a-factor signal peptide sequence by SnaB I and Not I restriction sites. The recombinant secretion vector pPIC9K/fGH, linearized by Sal I, was transformed into histidine-deficient Pichia pastoris strain GS115 by electroporation. We selected His+ -transformed methylotropic (His+, Mut+) yeast using histidine-absent medium containing dextrose (MD) or methanol (MM) as the only carbon source, and then screened the recombinant GS115 with multi-copy fGH genes by G418. The secretive expression of fGH was performed under the induction of methanol in shaking flask culture. The results showed that the fGH cDNA sequence amplified in this paper was basically in consistence with the published in GenBank. We achieved the secretive expression of recombinant fGH identified by SDS-PAGE and Western blotting. The fGH expression level was 119 mg/L, accounted for 34% of total proteins in fermentation medium.